Teva announces appointment of dr. angus grant to executive vice president, business development

Tel aviv, israel--(business wire)--teva pharmaceutical industries ltd. (nyse and tase: teva) today announced the appointment of dr. angus grant, ph.d., as evp, business development. dr. grant will begin his employment on august 1, 2023, and will be based out of teva's us headquarters in parsippany, nj. dr. grant joins teva with over 25 years of experience in the global pharmaceutical and biotech industry, with an exceptional track record across a variety of fields including business development.
TEVA Ratings Summary
TEVA Quant Ranking